Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity.

Benaiges E., Ceperuelo-Mallafré V., Madeira A., Bosch R., Núñez-Roa C., Ejarque M.

Prospective Study on Chronic Inflammation, published in Cell Oncol (Dordr) (2021) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Cell Oncol (Dordr) (2021)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
33710603
PMCID
PMC8338861
DOI
10.1007/s13402-021-00597-x
Citations
18

Abstract (original English)

Purpose Recent studies point to adipose-derived stem cells (ASCs) as a link between obesity and cancer. We aimed to determine whether survivin, which is highly secreted by ASCs from subjects with obesity, might drive a pro-tumoral phenotype in macrophages. Methods The effect of ASC conditioned medium on the macrophage phenotype was assessed by expression studies. Survivin intracellular localization and internalization were examined by subcellular fractionation and immunofluorescence, respectively. Loss- and gain-of-function studies were performed using adenoviral vectors, and gene expression patterns, migration and invasion capacities of cancer cells were examined. Heterotypic cultures of ASCs, macrophages and cancer cells were established to mimic the tumor microenvironment. Survivin-blocking experiments were used to determine the impact of survivin on both macrophages and cancer cells. Immunohistochemical analysis of survivin was performed in macrophages from ascitic fluids of cancer patients and healthy controls. Results We found that obese-derived ASCs induced a phenotypic switch in macrophages characterized by the expression of both pro- and anti-inflammatory markers. Macrophages were found to internalize extracellular survivin, generating hybrid macrophages with a tumor-associated phenotype that included secretion of survivin. Exogenous expression of survivin in macrophag

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueCaco-2 CellsCells, CulturedGene Expression ProfilingGene Expression Regulation, NeoplasticHEK293 CellsHT29 CellsHep G2 CellsHumansNeoplasms

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research